Cargando…

Correction: The sorafenib anti-relapse effect after alloHSCT is associated with heightened alloreactivity and accumulation of CD8+PD-1+ (CD279+) lymphocytes in marrow

Detalles Bibliográficos
Autores principales: Lange, Andrzej, Jaskula, Emilia, Lange, Janusz, Dworacki, Grzegorz, Nowak, Dorota, Simiczyjew, Aleksandra, Mordak-Domagala, Monika, Sedzimirska, Mariola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283549/
https://www.ncbi.nlm.nih.gov/pubmed/30521628
http://dx.doi.org/10.1371/journal.pone.0209108
_version_ 1783379180083216384
author Lange, Andrzej
Jaskula, Emilia
Lange, Janusz
Dworacki, Grzegorz
Nowak, Dorota
Simiczyjew, Aleksandra
Mordak-Domagala, Monika
Sedzimirska, Mariola
author_facet Lange, Andrzej
Jaskula, Emilia
Lange, Janusz
Dworacki, Grzegorz
Nowak, Dorota
Simiczyjew, Aleksandra
Mordak-Domagala, Monika
Sedzimirska, Mariola
author_sort Lange, Andrzej
collection PubMed
description
format Online
Article
Text
id pubmed-6283549
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-62835492018-12-20 Correction: The sorafenib anti-relapse effect after alloHSCT is associated with heightened alloreactivity and accumulation of CD8+PD-1+ (CD279+) lymphocytes in marrow Lange, Andrzej Jaskula, Emilia Lange, Janusz Dworacki, Grzegorz Nowak, Dorota Simiczyjew, Aleksandra Mordak-Domagala, Monika Sedzimirska, Mariola PLoS One Correction Public Library of Science 2018-12-06 /pmc/articles/PMC6283549/ /pubmed/30521628 http://dx.doi.org/10.1371/journal.pone.0209108 Text en © 2018 Lange et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Correction
Lange, Andrzej
Jaskula, Emilia
Lange, Janusz
Dworacki, Grzegorz
Nowak, Dorota
Simiczyjew, Aleksandra
Mordak-Domagala, Monika
Sedzimirska, Mariola
Correction: The sorafenib anti-relapse effect after alloHSCT is associated with heightened alloreactivity and accumulation of CD8+PD-1+ (CD279+) lymphocytes in marrow
title Correction: The sorafenib anti-relapse effect after alloHSCT is associated with heightened alloreactivity and accumulation of CD8+PD-1+ (CD279+) lymphocytes in marrow
title_full Correction: The sorafenib anti-relapse effect after alloHSCT is associated with heightened alloreactivity and accumulation of CD8+PD-1+ (CD279+) lymphocytes in marrow
title_fullStr Correction: The sorafenib anti-relapse effect after alloHSCT is associated with heightened alloreactivity and accumulation of CD8+PD-1+ (CD279+) lymphocytes in marrow
title_full_unstemmed Correction: The sorafenib anti-relapse effect after alloHSCT is associated with heightened alloreactivity and accumulation of CD8+PD-1+ (CD279+) lymphocytes in marrow
title_short Correction: The sorafenib anti-relapse effect after alloHSCT is associated with heightened alloreactivity and accumulation of CD8+PD-1+ (CD279+) lymphocytes in marrow
title_sort correction: the sorafenib anti-relapse effect after allohsct is associated with heightened alloreactivity and accumulation of cd8+pd-1+ (cd279+) lymphocytes in marrow
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283549/
https://www.ncbi.nlm.nih.gov/pubmed/30521628
http://dx.doi.org/10.1371/journal.pone.0209108
work_keys_str_mv AT langeandrzej correctionthesorafenibantirelapseeffectafterallohsctisassociatedwithheightenedalloreactivityandaccumulationofcd8pd1cd279lymphocytesinmarrow
AT jaskulaemilia correctionthesorafenibantirelapseeffectafterallohsctisassociatedwithheightenedalloreactivityandaccumulationofcd8pd1cd279lymphocytesinmarrow
AT langejanusz correctionthesorafenibantirelapseeffectafterallohsctisassociatedwithheightenedalloreactivityandaccumulationofcd8pd1cd279lymphocytesinmarrow
AT dworackigrzegorz correctionthesorafenibantirelapseeffectafterallohsctisassociatedwithheightenedalloreactivityandaccumulationofcd8pd1cd279lymphocytesinmarrow
AT nowakdorota correctionthesorafenibantirelapseeffectafterallohsctisassociatedwithheightenedalloreactivityandaccumulationofcd8pd1cd279lymphocytesinmarrow
AT simiczyjewaleksandra correctionthesorafenibantirelapseeffectafterallohsctisassociatedwithheightenedalloreactivityandaccumulationofcd8pd1cd279lymphocytesinmarrow
AT mordakdomagalamonika correctionthesorafenibantirelapseeffectafterallohsctisassociatedwithheightenedalloreactivityandaccumulationofcd8pd1cd279lymphocytesinmarrow
AT sedzimirskamariola correctionthesorafenibantirelapseeffectafterallohsctisassociatedwithheightenedalloreactivityandaccumulationofcd8pd1cd279lymphocytesinmarrow